[1] |
ZHU Li, WEI Bing, LIAO Shi'e, ZHANG Chao, ZHENG Xiaoyu, LIU Yajun.
Effects of single nucleotide polymorphism of drug metabolizing enzyme cytochrome P450 on the efficacy of inhaled cortisol hormone in asthmatic children
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 536-543.
|
[2] |
FU Hong, TIAN Lei.
Individualized precision therapy for patients with ischemic stroke and hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876.
|
[3] |
ZHENG Binjie, LIU Na, ZENG Xiangchang, HUANG Xinyi, CHEN Lulu, OU-YANG Dongsheng.
Effects of gut microbiota on pharmacokinetics and its consideration in the evaluation of the consistency of quality and efficacy of generic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 662-671.
|
[4] |
WU Yi, WANG Rangrang, WANG Zhaowen, FAN Junwei.
Effect of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in early postoperative period of liver transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1268-1275.
|
[5] |
PEI Tong, GAO Dan, WANG Chunhua, CHEN Xiaoping, GONG Shili, HU Xiao, HU Chaoying, ZHANG Lan.
Pharmacokinetics and bioequivalence study of indapamide tablets
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1009-1014.
|
[6] |
LIU Li, PENG Jinfu, GUO Chengxian, YANG Xiding, LI Haigang, YANG Guoping.
Regulative effects of miR-150 on CYP3A4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 749-754.
|
[7] |
NAN Feng, XU Nan, CHEN Zhihui, XIANG Jin, LIANG Maozhi, TAO Zeting, YE Wei.
Rapid and sensitive determination of amoxicillin in human plasma by LC-MS/MS and the bioavailability of two amoxicillin capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 73-77.
|
[8] |
HUANG Wei, HU Xiao.
Study on the mechanism of cytochrome P450 3A4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 223-229.
|
[9] |
TANG Xia, XIN Hua-wen, LI Wei-liang, OUYANG Meng.
Study of the effects of Berberine on CYP3A4 and P-gp in HepG2 cells and its mechanism in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 7-13.
|
[10] |
YU Shan-shan, ZHANG Zheng-fu, LI Zheng-qi.
Investigation and countermeasures to the current status of the generics quality consistency evaluation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 118-120.
|
[11] |
DAI Ying, ZHANG Jing, LIN Mei-qing, SONG Hong-tao.
Research current situation and progress on pharmacogenomics and personalized medicine of cyclosporine A
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 931-936.
|
[12] |
OUYANG Cang-hong, XIE Juan.
Study on the relationship between the MDR1 and CYP3A genetic polymorphisms and serum digoxin concentration in 111 patients with chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 291-296.
|
[13] |
WANG Rong, CHEN Ke-rui, LIU Xiao-mei, TANG Hui-en, HE Zhen-yu.
Investigation of the rs28371759 polymorphism of CYP3A4 gene in Guangdong population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1255-1258.
|
[14] |
HU Dong-li,CHEN Yao, SHEN Jie, XIE Hai-tang, QIAN Rong-hua,TAN Zhi-rong, WANG Yi-cheng, WANG Dan, ZHOU Hong-hao.
UPLC-MS/MS determination of tamoxifen and its metabolites in human plasma and application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(7): 773-778.
|
[15] |
LI Yun, HE Fang, ZENG Cai-wen, LIU Lin-lin, XIA Chun-hua.
Effect of CYP2C9, CYP2C19, CYP3A4 polymorphism on metabolism of sulfonyluea antidiabetic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(5): 582-587.
|